RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
34.47
0.00 (-0.01%)
At close: Dec 5, 2025, 4:00 PM EST
33.82
-0.65 (-1.87%)
After-hours: Dec 5, 2025, 6:43 PM EST

RAPT Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
9552138556721,085485
Upgrade
Market Cap Growth
2383.63%-75.05%27.19%-38.08%123.77%-19.54%
Upgrade
Enterprise Value
800120677484874362
Upgrade
Last Close Price
34.4712.64198.80158.40293.84158.00
Upgrade
PS Ratio
---440.09284.6196.19
Upgrade
PB Ratio
3.821.125.812.745.824.66
Upgrade
P/TBV Ratio
6.281.125.812.745.824.66
Upgrade
EV/Sales Ratio
---317.25229.3371.83
Upgrade
Debt / Equity Ratio
0.020.020.050.04--
Upgrade
Asset Turnover
---0.010.020.05
Upgrade
Quick Ratio
11.764.787.2817.5119.779.50
Upgrade
Current Ratio
12.044.877.4117.7720.119.85
Upgrade
Return on Equity (ROE)
-85.37%-77.09%-59.56%-38.86%-47.63%-59.66%
Upgrade
Return on Assets (ROA)
-51.35%-41.13%-36.13%-23.07%-27.24%-32.67%
Upgrade
Return on Capital (ROIC)
-55.17%-48.84%-38.92%-24.34%-29.77%-37.52%
Upgrade
Return on Capital Employed (ROCE)
-73.90%-70.90%-83.90%-34.00%-36.60%-49.60%
Upgrade
Earnings Yield
-11.06%-60.90%-13.66%-12.48%-6.38%-10.91%
Upgrade
FCF Yield
-9.07%-39.12%-11.49%-10.66%-5.69%-8.43%
Upgrade
Buyback Yield / Dilution
-347.95%-6.32%-17.82%-18.80%-13.49%-455.27%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.